Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia.
Herbaux C, Bertrand E, Marot G, Roumier C, Poret N, Soenen V, Nibourel O, Roche-Lestienne C, Broucqsault N, Galiègue-Zouitina S, Boyle EM, Fouquet G, Renneville A, Tricot S, Morschhauser F, Preudhomme C, Quesnel B, Poulain S, Leleu X. Herbaux C, et al. Among authors: leleu x. Oncotarget. 2016 Jun 7;8(34):57451-57459. doi: 10.18632/oncotarget.9917. eCollection 2017 Aug 22. Oncotarget. 2016. PMID: 28924457 Free PMC article.
Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21).
Leroy H, de Botton S, Grardel-Duflos N, Darre S, Leleu X, Roumier C, Morschhauser F, Lai JL, Bauters F, Fenaux P, Preudhomme C. Leroy H, et al. Among authors: leleu x. Leukemia. 2005 Mar;19(3):367-72. doi: 10.1038/sj.leu.2403627. Leukemia. 2005. PMID: 15674426 Clinical Trial.
Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia.
Moreau AS, Sebti Y, Duhamel A, Roccaro AM, Coiteux V, Gastinne T, Le Friec G, Burwick N, Amiot L, Ho AW, Poulain S, Hennache B, Hunter ZR, Dessaint JP, Ghobrial IM, Treon SP, Facon T, Zorn E, Leleu X. Moreau AS, et al. Among authors: leleu x. Eur J Haematol. 2008 Jun;80(6):503-9. doi: 10.1111/j.1600-0609.2008.01060.x. Epub 2008 Mar 10. Eur J Haematol. 2008. PMID: 18331603
Update on therapeutic options in Waldenström macroglobulinemia.
Leleu X, Gay J, Roccaro AM, Moreau AS, Poulain S, Dulery R, Champs BB, Robu D, Ghobrial IM. Leleu X, et al. Eur J Haematol. 2009 Jan;82(1):1-12. doi: 10.1111/j.1600-0609.2008.01171.x. Eur J Haematol. 2009. PMID: 19087134 Free PMC article. Review.
[Waldenström's macroglobulinemia].
Poulain S, Wemeau M, Balkaran S, Hivert B, Hautecoeur A, Rossignol J, Fernandez J, Daudignon A, Roumier C, Soenen V, Lepelley P, Lai JL, Morel P, Leleu X. Poulain S, et al. Among authors: leleu x. Rev Med Interne. 2010 May;31(5):385-94. doi: 10.1016/j.revmed.2009.07.016. Epub 2010 Apr 3. Rev Med Interne. 2010. PMID: 20363537 French.
In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.
Berthon C, Driss V, Liu J, Kuranda K, Leleu X, Jouy N, Hetuin D, Quesnel B. Berthon C, et al. Among authors: leleu x. Cancer Immunol Immunother. 2010 Dec;59(12):1839-49. doi: 10.1007/s00262-010-0909-y. Epub 2010 Sep 4. Cancer Immunol Immunother. 2010. PMID: 20814675 Free PMC article.
398 results